eli lilly glp-1 mounjaro endowment targets FDA approval for weight loss medication Eli Lilly launches weight-loss drug

Semaglutide works by mimicking the action of GLP-1, a natural hormone produced in the intestines that helps regulate blood sugar levels

[DOI] [PubMed] [Google Scholar] 59.Kim D., Wang L., Beconi M., Eiermann G.J., Fisher M.H., He H., Hickey G.J., Kowalchick J.E., Leiting B., Lyons K., et al

Zepbound is approved by the FDA as a weight loss management treatment for people with obesity or those who are overweight with at least one weight-related condition such as high blood pressure

doi: 10.1016/j.cardfail.2012.07.009

Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner